Transforming growth factor-beta signaling in normal and malignant hematopoiesis.
about
A role of Miz-1 in Gfi-1-mediated transcriptional repression of CDKN1ABMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1Cytoplasmic PML function in TGF-beta signallingAberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.A road map toward defining the role of Smad signaling in hematopoietic stem cells.Growth regulation of simian and human AIDS-related non-Hodgkin's lymphoma cell lines by TGF-beta1 and IL-6.Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure.Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner.p14ARF, p15INK4b and p16INK4a methylation status in chronic myelogenous leukemia.Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptorRole of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphomaTGFbeta/BMP inhibits the bone marrow transformation capability of Hoxa9 by repressing its DNA-binding ability.Binding of a Smad4/Ets-1 complex to a novel intragenic regulatory element in exon12 of FPGS underlies decreased gene expression and antifolate resistance in leukemiaIdentification of a Novel Link between the Protein Kinase NDR1 and TGFβ Signaling in Epithelial CellsBerbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity.TGF-β signaling and its role in the regulation of hematopoietic stem cells.Galectins in hematological malignancies.Raf and VEGF: emerging therapeutic targets in Kaposi's sarcoma-associated herpesvirus infection and angiogenesis in hematopoietic and nonhematopoietic tumors.A novel co-operative mechanism linking TGFβ and Lyn kinase activation to imatinib resistance in chronic myeloid leukaemia cells.Lysophosphatidic acid-induced p21Waf1 expression mediates the cytostatic response of breast and ovarian cancer cells to TGFβ.KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor.Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1.SNP selection in genome-wide association studies via penalized support vector machine with MAX test.Establishment and regulation of the HSC niche: Roles of osteoblastic and vascular compartments.Overexpression of Evi-1 oncoprotein represses TGF-β signaling in colorectal cancer.The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation.Abnormal expression of TGF-beta type II receptor isoforms contributes to acute myeloid leukemia.The role of Smad signaling in vascular and hematopoietic development revealed by studies using genetic mouse models.The role of Smad signaling in hematopoiesis and translational hematology.Moving from the laboratory bench to patients' bedside: considerations for effective therapy with stem cells.Transforming Growth Factor β Drives Hemogenic Endothelium Programming and the Transition to Hematopoietic Stem Cells.Cell intrinsic and extrinsic regulation of leukemia cell metabolism.Regulation of Hematopoiesis and Hematological Disease by TGF-β Family Signaling Molecules.Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease.Upregulation of the TGFbeta signalling pathway by Bcr-Abl: implications for haemopoietic cell growth and chronic myeloid leukaemia.Nicotine inhibits myofibroblast differentiation in human gingival fibroblasts.Targeting self-renewal pathways in myeloid malignancies.Transforming growth-interacting factor (TGIF) regulates proliferation and differentiation of human myeloid leukemia cells.A cross-talk between stromal cell-derived factor-1 and transforming growth factor-beta controls the quiescence/cycling switch of CD34(+) progenitors through FoxO3 and mammalian target of rapamycin.
P2860
Q24301395-4114E25C-A46F-468A-B0E3-041F1175A88DQ24806130-C36AB0F4-4296-45C7-9B2F-2ED7073D1E98Q28281152-0964D9C4-E423-4937-94AF-A83C20E0DB2CQ31149409-D38D72E5-35A0-417D-9682-25BA57EAE831Q33229597-B809EBFB-2F20-45C3-A524-3122BBF15D20Q33275612-707DB79C-EFAB-47DB-961C-53B58CBD9FF9Q33556254-8BAFA08B-065D-45B1-B6B1-06A496CD5DABQ33724405-779F0BC5-E71B-4BF6-A416-BA5F73D1B4F2Q33981430-33E1F0C0-AEA5-4C45-86DB-9AA84A5103D3Q34067009-9191793B-17B2-4BF6-B192-1CAC0F8A084EQ34132159-CC3A0791-2C54-4504-9281-AD5A4B162FD7Q34437606-5F2E4E68-18A0-4496-9FDF-725022B6E8F3Q34545421-D4446922-9538-4C87-AE63-1F4144A1E289Q34619287-A15C0A15-BEB7-4BEE-B208-0C2DE00572EAQ34806677-7ED5E2A2-3466-4F02-9DA9-4A13546D40CEQ35100843-E64AD161-FD68-423C-B27E-3D8E8BDBB780Q35593959-FD4F2914-0412-46B7-913B-B219247E06BFQ35824985-A8C075A8-ED81-4A4D-80E1-C672A93C3DE4Q35911472-F37A8D57-44B0-4102-A78E-CEE2D62AB47FQ36071873-BE197E86-E99F-4C69-B08E-8514E3753DF2Q36073708-0DA0FA35-128C-4D60-8E38-3D97B19B9388Q36591375-4AC92C0D-3652-41FA-BE4D-E6A230EB216FQ37083557-DF57B077-50B5-489C-8854-1D5414F76398Q37224697-C633A16E-13A8-4143-95B7-70626165FE91Q37579927-373C4A2C-4E2E-479D-865C-B74B5B283928Q37580699-0D40F1AD-A49F-4973-84E8-540B64C6A5DDQ37644979-2D985E83-226A-4E53-827B-0A98125E272BQ37705779-31E0AB43-684E-4626-B804-8CF9D81B22A3Q37769462-7525E006-808F-4ACE-97F8-59F96A76CFF8Q37874928-31A144F5-E268-40F6-A924-D3B21208AF5BQ37949680-CE72115F-95E5-4115-8F71-CEB959D425AAQ38291377-B279BB11-4219-49B3-983B-7FAEFCA916ABQ38742000-85D65C86-AB34-45AF-B4E3-BED35212970FQ39134073-536C87A8-CE4E-41B1-B848-C475D3C70892Q39512034-E033D992-E1FE-41D3-B204-6E877F0DFBBBQ40161241-4A026EB8-C6AE-449B-8157-770A68F90639Q40289722-783F364A-BCB1-4923-8E36-B224EF578773Q41104001-C8CECE2A-77B6-4EC9-BFAF-B22D9746A5ABQ41128284-96197649-0F43-4820-9D3F-3C3AFE28E60FQ45006321-155F7D85-76E5-4897-BBFF-5D36CFD8262B
P2860
Transforming growth factor-beta signaling in normal and malignant hematopoiesis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Transforming growth factor-beta signaling in normal and malignant hematopoiesis.
@ast
Transforming growth factor-beta signaling in normal and malignant hematopoiesis.
@en
type
label
Transforming growth factor-beta signaling in normal and malignant hematopoiesis.
@ast
Transforming growth factor-beta signaling in normal and malignant hematopoiesis.
@en
prefLabel
Transforming growth factor-beta signaling in normal and malignant hematopoiesis.
@ast
Transforming growth factor-beta signaling in normal and malignant hematopoiesis.
@en
P2860
P356
P1433
P1476
Transforming growth factor-beta signaling in normal and malignant hematopoiesis.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403069
P577
2003-09-01T00:00:00Z